Carnegie Capital Asset Management, LLC Pfizer Inc Transaction History

Carnegie Capital Asset Management, LLC

$3.18 Billion
Q2 2024

A detailed history of Carnegie Capital Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 110,025 shares of PFE stock, worth $3.27 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

110,025

Previous 147,386 25.35%

Holding current value

$3.27 Million

Previous $4.09 Million 24.72%

% of portfolio

0.1%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$25.26 - $29.6 $943,738 - $1.11 Million	-37,361 Reduced 25.35%	110,025 $3.08 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $309,592 - $355,511	11,958 Added 8.83%	147,386 $4.09 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $1.34 Million - $1.74 Million	-51,315 Reduced 27.48%	135,428 $3.9 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $483,500 - $565,163	-15,067 Reduced 7.47%	186,743 $6.19 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $419,967 - $485,892	11,627 Added 6.11%	201,810 $7.4 Million
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $1.8 Million - $2.35 Million	-45,761 Reduced 19.39%	190,183 $7.76 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $358,883 - $468,482	8,596 Added 3.78%	235,944 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $45,116 - $55,076	1,031 Added 0.46%	227,348 $9.95 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $1.82 Million - $2.15 Million	39,015 Added 20.83%	226,317 $11.9 Million
Q2 2022 Jul 13, 2022	SELL	$46.53 - $55.17 $1.34 Million - $1.58 Million	-28,729 Reduced 13.3%	187,302 $7.33 Million
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $818,284 - $1.01 Million	17,886 Added 9.03%	216,031 $11.2 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $180,320 - $267,295	4,364 Added 2.25%	198,145 $11.7 Million
Q3 2021 Oct 08, 2021	BUY	$39.25 - $50.42 $254,300 - $326,671	6,479 Added 3.46%	193,781 $8.34 Million
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $743,265 - $841,994	20,698 Added 12.42%	187,302 $7.33 Million
Q1 2021 Apr 12, 2021	SELL	$33.49 - $37.77 $343,473 - $387,369	-10,256 Reduced 5.8%	166,604 $6.04 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $233,687 - $297,153	6,982 Added 4.11%	176,860 $6.51 Million
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $206,089 - $241,789	-6,491 Reduced 3.68%	169,878 $6.23 Million
Q2 2020 Jul 09, 2020	SELL	$30.12 - $36.54 $81,143 - $98,438	-2,694 Reduced 1.5%	176,369 $5.77 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $579,036 - $827,317	-21,422 Reduced 10.69%	179,063 $5.83 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $1.82 Million - $2.06 Million	-55,138 Reduced 21.57%	200,485 $7.86 Million
Q3 2019 Nov 20, 2019	SELL	$32.49 - $42.13 $344,458 - $446,662	-10,602 Reduced 3.98%	255,623 $9.19 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $121,405 - $136,310	3,283 Added 1.25%	266,225 $11.5 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $5.11 Million - $5.62 Million	136,345 Added 107.7%	262,942 $11.2 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.29 Million - $1.47 Million	-33,543 Reduced 20.95%	126,597 $5.53 Million
Q3 2018 Nov 27, 2018	BUY	$34.47 - $41.81 $1.31 Million - $1.59 Million	38,133 Added 31.25%	160,140 $6.97 Million
Q2 2018 Aug 16, 2018	BUY	$32.98 - $35.16 $256,518 - $273,474	7,778 Added 6.81%	122,007 $4.97 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $196,661 - $228,154	6,163 Added 5.7%	114,229 $4.06 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $479,276 - $508,528	14,410 Added 15.39%	108,066 $3.78 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $74,214 - $81,755	2,394 Added 2.62%	93,656 $3.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	91,262	91,262 $3.01 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.

Account

Carnegie Capital Asset Management, LLC Pfizer Inc Transaction History